✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyRegulationQuality ControlPatient SafetyIllicit Market Why This MattersLarge-scale illicit cannabis operations represent unregulated production...
Be honest, would you smoke the trash weed?
Your endocannabinoid system doesn't negotiate with low-grade flower, and neither should your therapeutic outcomes. Quality control matters when you're treating symptoms, not just chasing novelty. Via r/trees Further Reading Research DigestResearch Digest:...
Nature’s CBD Gummies vs. Pharmacist-Grade Brands: What’s Really in That Bottle?
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic NatureSCbdGummies Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Ascend and NuProject Launch ROOTS Program to Prepare Cannabis Businesses for …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Supply ChainProduct QualityIndustry StandardsAccessPolicy Why This MattersAs cannabis transitions from state-regulated markets to potential...
The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …
WHY IT MATTERS: Patients and adult consumers purchasing cannabis from licensed New York dispensaries should check current recall lists and verify with their dispensary that any products they have recently purchased or plan to purchase have not been flagged for removal. CLINICAL OVERVIEW: Product recalls in regulated cannabis markets typically arise when testing laboratories identify contaminants such as pesticides, heavy metals, microbial agents, or inaccurate potency labeling that fall outside state-mandated safety thresholds. When a testing facility’s results are called into question or when products are found to be non-compliant, state regulators are obligated to pull those items from dispensary shelves to protect consumers.
Researcher: Remediated cannabis may still have harmful mold – MJBizDaily
WHY IT MATTERS: If you are using cannabis purchased from a dispensary, you should know that passing a state lab test does not guarantee your product is free from all harmful mold species, which is especially important if you have a weakened immune system or chronic lung conditions. CLINICAL OVERVIEW: Recent research highlights that cannabis products which have undergone remediation processes to address mold contamination may still harbor harmful fungal organisms that current state-mandated testing protocols fail to detect. This raises significant clinical concerns because immunocompromised patients and those with respiratory conditions may be unknowingly exposed to mycotoxins and viable mold spores, and the assumption that vaporization eliminates these contaminants appears to be unsupported by the evidence.
5 Transformative Effects of Cannabis Rescheduling: Medical Insight
In a recent landmark announcement on Cannabis Rescheduling, President Biden expressed his administration's commitment to support the rescheduling of cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This...